Researchers have found a drug that can help the brain grow new cells, and they said their study may lead to ways to improve experimental Alzheimer’s drugs.
The researchers’ work, done on rodents, builds on findings that all mammals, including humans, make brain cells throughout their lives. Most of these die, but this drug helps more of the baby cells survive and grow to become functioning brain cells.
“We make new neurons every day in our brain,” Andrew Pieper of the University of Texas Southwestern Medical Center in Dallas who worked on the study, said in a telephone interview. “What our compound does is allow more of them to survive.”
The compound is called P7C3 for now, and the researchers have already started tweaking it to make it more effective. They said it seems safe and appears to work even when taken as a pill.
The compound is similar to Medivation and Pfizer experimental Alzheimer’s drug, Dimebon, and may provide ways to improve its effects, Pieper and colleagues reported in the journal Cell.
It is also similar to some compounds owned by Serono, the researchers said.
Dimebon, originally a Russian-made antihistamine also known as latrepirdine, failed in a clinical trial for Alzheimer’s disease in March.
“For the sake of patients suffering from Alzheimer’s disease, it is hoped that the apparently marginal clinical utility of Dimebon might be enhanced by improvements in both its potency and ceiling of proneurogenic, neuroprotective efficacy,” the researchers wrote.
“If so, our work offers concrete assays for the development of improved versions of these neuroprotective drugs.”
Alzheimer’s gradually destroys the brain and affects 26 million people globally. Drugs, such as Pfizer’s Aricept, improve symptoms only minimally.
The researchers went through 1,000 representative compounds from 300,000 chemicals, pooled them, and administered them to mice. They then dissected the brains to see whether any of the mice had made new cells in the hippocampus, a region of the brain associated with learning and memory.
They eventually narrowed the field to P7C3.
When they gave it to old rats for two months, the elderly rodents did far better than other old rats in learning their way around a water maze.
When dissected, the treated rats turned out to have three times the usual number of newborn neurons in a brain region called the dentate gyrus.
They made a derivative of P7C3 called A20 that worked even better
When the researchers tested Dimebon and the Serono compounds, they found these drugs also stimulated the growth of new brain cells. Being able to target their effects could lead to better drugs to treat Alzheimer’s and perhaps other diseases that destroy brain cells like strokes and amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease.
“This striking demonstration of a treatment that stems age-related cognitive decline in living animals points the way to potential development of the first cures that will address the core illness process in Alzheimer’s disease,” said Dr. Thomas Insel, director of the National Institute on Mental Health, which helped pay for the study.
Quality Inn Winnipeg Extended Stay Hotel
Related Websites - Children exposed daily to untested personal-care products (Source: Environmental Working Group) – From baby shampoo to diaper wipes, children are exposed every day to products containing chemicals that have not been assessed for their hazards to children,...
- HP buying Palm for 1.2 billion dollars [/caption] US computer giant Hewlett-Packard, in a bid to become a player in the fast-growing smartphone market, said Wednesday it was buying struggling US mobile phone maker Palm for 1.2...
- SOUTH KOREA - Seoul lifts ban on stem cell research Image via Wikipedia The South Korean bioethics committee has lifted a ban on human stem cell research. The decision will now allow for work on human embryonic stem cells to...
- Skin cells transform to liver cells In a fresh demonstration of science's newfound ability to alter the basic units of human life, researchers at the Medical College of Wisconsin have turned the cells in human skin...
- Can Cars Run On Water? Dear EarthTalk: Iâve heard that cars can be modified to run on water. How is this possible? There are a number of online marketing offers of kits that will convert...
- Judge stops federal funding of embryonic stem cell research [/caption] Washington -- A U.S. district judge granted a preliminary injunction Monday to stop federal funding of embryonic stem cell research that he said destroys embryos, ruling it went against...
- Solution to Sugar Addiction I've talked about the possibility of being addicted to sugar and more of the specifics on how sugar acts like a drug in some individuals. This post will cover the...
optionMONSTER’s Heat Seeker tracking system detected the purchase of 11,111 November 22.50 calls for about $5.40 against open interest of only 123 contracts. The trade came just seconds after the same number of October 20 calls were sold for $7.60 against open interest of 11,141.